Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

06/11/04 Healthcast: Drug For Brain Tumor Patients        

06/11/04 Targeted Treatment Takes Aim at Cancer        

06/08/04 Immunohistochemical detection of EGFRvIII and prognostic significance in patients with malignant glioma enrolled in NCCTG clinical trials.        

06/08/04 Interim report of the JROSG99-1 multi-institutional randomized trial, comparing radiosurgery alone vs. radiosurgery plus whole brain irradiation for 1-4 brain metastases.        

06/08/04 Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.        

06/08/04 Multicentre phase II study of imatinib mesylate in patients with recurrent glioblastoma: An EORTC: NDDG/BTG Intergroup Study.        

06/08/04 NCCTG phase II trial of CCI-779 in recurrent glioblastoma multiforme (GBM).        

06/08/04 One week on/one week off regimen of temozolomide for recurrent glioblastoma: A phase II study.        

06/08/04 Operable benign meningioma patients appear to have expected survival that is equivalent to a normal United States population.        

06/08/04 PCV and/or TMZ chemotherapy in 255 gliomas. Analysis of the clinical experience from a neuro-oncology data-base.        

06/08/04 Pegylated liposomal doxorubicin plus temozolamide in the salvage treatment of brain metastases: The update.        

06/08/04 Phase I/II trial of a twice-daily regimen of temozolomide and celecoxib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.        

06/08/04 Phase I/II trial of intravenous OV001 oncolytic virus in resistant glioblastoma multiforme (GBM).        

06/08/04 Phase II study of thalidomide and daily cyclophosphamide for adults with malignant glioma.        

06/08/04 Phase II study of ZD1839 in patients with newly diagnosed grade 4 astrocytoma.        

06/08/04 Phase II trial of copper depletion as angiosuppressive treatment in newly diagnosed Glioblastoma Multiforme: Final report.        

06/08/04 Phase II trial of functional imaging-optimized stereotactic fractionated radiotherapy plus temozolomide for recurrent high-grade glioma.        

06/08/04 Phase II trial of iodine 131-labeled murine anti-tenascin monoclonal anti-body 81C6 (M81C6) via surgically created resection cavity in the treatment of patients with recurrent malignant brain tumors.        

06/08/04 Phase II trial of radiosurgery (RS) for 1 to 3 newly diagnosed brain metastases from renal cell, melanoma, and sarcoma: An Eastern Cooperative Oncology Group Study (E6397).        

---

Displaying Stories 5290 to 5309 of 7812
Previous 20           Next 20